1. PROthrombin Time Electronic ASsistant

2. Patients
Venous
Thrombosis
Strokes
Pulmonary
Embolism
Artificial
Aortic Valve
Arterial
Embolism

3. HISTORY
STOCK &
DOSAGE
REMINDERSFIND A LAB
COMMUNITY

4. Collecting statistical data
for better future
treatments
Creating a network-
community between
patients

5. Niche business strategy:
narrow-scope segment of the market with
customer-oriented service.
Software-as-a-service approach.
Market Entry Point:
Distribution to the end-user through the web
POS and mobile application markets.
Size of the Market:
100.000.000 globally
Target group:
Patients who receive a blood-regulating,
anticoagulant medication.
PRO.T.E.AS
MARKETING PLAN

6. Competitive advantage :
Introducing an innovative service to a very specific market segment.
A unique service to facilitate and optimize the anticoagulant medication
treatment and monitoring.
No sufficient
bargaining power of
suppliers
Not known
substitute services
until now
Not known existing
rivalry competitors
No sufficient
bargaining power of
customers
• Low switching costs
• Expected
Retaliation

7. Business Model

8. NUMBERS…

9. SWOT Analysis
S
No fixed costs
Low operating costs
High Added Value Database
W
Easily initiated
business model
Legal regulations
T
No entry barriers
Low switching costs
Emerging Competition
O
Data harvesting for new
medications
New Market
Business model adaptable to
possible competition

10. A challenging future…
MAKE IT
HAPPEN
HELP LAUNCH
IGNITE
FURTHER
MED APPS
ELDERLY PATIENTS

11. THANK YOU MENTORS & ORGANIZERS
MARIOS BIKOS ~ THRASYVOULOS KARYDIS ~ FILIPPOS KALLIARAS
NIKOS BARBAKOS ~ THANASIS PARASCHOS
TEAM

12. PROthrombin Time Electronic ASsistant